HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tian-Li Yue Selected Research

arginine methyl ester

8/2008Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tian-Li Yue Research Topics

Disease

3Myocardial Infarction
02/2009 - 02/2002
3Ischemia
05/2008 - 02/2002
2Body Weight (Weight, Body)
01/2018 - 01/2013
2Insulin Resistance
01/2013 - 02/2005
2Dyslipidemias (Dyslipidemia)
01/2013 - 05/2008
2Hypertension (High Blood Pressure)
01/2013 - 06/2007
2Infarction (Infarctions)
05/2008 - 02/2005
2Reperfusion Injury
05/2008 - 02/2005
2Cardiovascular Diseases (Cardiovascular Disease)
06/2007 - 06/2002
2Myocardial Ischemia (Ischemic Heart Diseases)
04/2004 - 03/2002
2Hypercholesterolemia
04/2004 - 12/2003
2Atherosclerosis
04/2004 - 12/2003
1Hypertriglyceridemia
01/2013
1Glucose Intolerance
01/2013
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2013
1Heart Injuries
02/2009
1Heart Diseases (Heart Disease)
02/2009
1Shock
08/2008
1Vascular Ring
08/2008
1Hemorrhage
08/2008
1Obesity
05/2008
1Inflammation (Inflammations)
05/2008
1Cardiomegaly (Heart Hypertrophy)
06/2007
1Type 2 Diabetes Mellitus (MODY)
12/2003
1Myocardial Reperfusion Injury
02/2002

Drug/Important Bio-Agent (IBA)

2Peroxidase (Myeloperoxidase)IBA
02/2009 - 02/2002
2p38 Mitogen-Activated Protein KinasesIBA
06/2007 - 02/2002
2Rosiglitazone (Avandia)FDA Link
02/2005 - 04/2004
2Insulin (Novolin)FDA Link
02/2005 - 03/2002
2PPAR-gamma AgonistsIBA
04/2004 - 12/2003
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
04/2004 - 12/2003
1CholesterolIBA
01/2018
1choloylglycine hydrolaseIBA
01/2018
1Hydroxysteroid DehydrogenasesIBA
01/2013
15- (4- (trimethylammonium)phenyl)- 10,15,20- tris(2,4,6- trimethoxyphenyl)porphyrinIBA
01/2013
1GlucocorticoidsIBA
01/2013
1ReninIBA
01/2013
1PPAR gammaIBA
02/2009
1Caspase 3 (Caspase-3)IBA
02/2009
1N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA
08/2008
1BuffersIBA
08/2008
1Ruthenium RedIBA
08/2008
1arginine methyl esterIBA
08/2008
1Nitric Oxide Synthase (NO Synthase)IBA
08/2008
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
08/2008
1PPAR deltaIBA
05/2008
1Troponin IIBA
05/2008
1(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA
05/2008
1MAP-kinase-activated kinase 2IBA
06/2007
1Superoxides (Superoxide)IBA
06/2007
1Messenger RNA (mRNA)IBA
06/2007
1Angiotensin IIIBA
06/2007
1Selective Estrogen Receptor Modulators (SERM)IBA
06/2002
1Therapeutic UsesIBA
06/2002
1Estrogens (Estrogen)FDA Link
06/2002
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
03/2002
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
03/2002
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2002
1SB 239063IBA
02/2002

Therapy/Procedure

1Ligation
02/2005
1Glycemic Control
12/2003